{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:37:50Z","timestamp":1789558670323,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.aace.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T02:55:20Z","timestamp":1649386520000},"page":"163-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Emphysematous Cystitis and Urinary Retention in a Male Patient With Diabetes Mellitus Type 2 Treated With Empagliflozin"],"prefix":"10.1016","volume":"8","author":[{"given":"Gina M.","family":"Brock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Roosevelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aace.2022.04.002_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1464-410X.2007.06930.x","article-title":"Emphysematous cystitis: a review of 135 cases","volume":"100","author":"Thomas","year":"2007","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.aace.2022.04.002_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2169\/internalmedicine.53.1121","article-title":"Emphysematous cystitis: a review of the literature","volume":"53","author":"Amano","year":"2014","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.aace.2022.04.002_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00467-019-04324-5","article-title":"A\u00a0child with urosepsis and a bladder with a halo: answers","volume":"35","author":"Sharma","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.aace.2022.04.002_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jdi.13189","article-title":"Incidence of severe urinary tract infections not increased by initiating sodium-glucose cotransporter 2 inhibitors","volume":"11","author":"Yokoyama","year":"2020","journal-title":"J\u00a0Diabetes Investig"},{"issue":"3","key":"10.1016\/j.aace.2022.04.002_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1148\/radiographics.22.3.g02ma06543","article-title":"Emphysematous infections of the abdomen and pelvis: a pictorial review","volume":"22","author":"Grayson","year":"2002","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.aace.2022.04.002_bib6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.dsx.2019.04.035","article-title":"A\u00a0complete review of empagliflozin: most specific and potent SGLT2 inhibitor used for the treatment of type 2 diabetes mellitus","volume":"13","author":"Chawla","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"10.1016\/j.aace.2022.04.002_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M18-3136","article-title":"Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study","volume":"171","author":"Dave","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.aace.2022.04.002_bib8","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1038\/s41598-017-02733-w","article-title":"Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.aace.2022.04.002_bib9","first-page":"3695101","article-title":"Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a pharmacovigilance study with data from the U.S. FDA Adverse Event Reporting System","volume":"2020","author":"Hu","year":"2020","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.aace.2022.04.002_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-219335","article-title":"Caution advised with dapagliflozin in the setting of male urinary tract outlet obstruction","volume":"2017","author":"Hall","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.aace.2022.04.002_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.urology.2012.02.023","article-title":"Clinical outcomes of nonoperative management in emphysematous urinary tract infections","volume":"79","author":"Bjurlin","year":"2012","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.aace.2022.04.002_bib12","first-page":"281","article-title":"Emphysematous cystitis: rapid resolution of symptoms with hyperbaric treatment: a case report","volume":"31","author":"McCabe","year":"2004","journal-title":"Undersea Hyperb Med"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060522000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060522000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:32:19Z","timestamp":1762497139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060522000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2376060522000256"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2022.04.002","relation":{},"ISSN":["2376-0605"],"issn-type":[{"value":"2376-0605","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emphysematous Cystitis and Urinary Retention in a Male Patient With Diabetes Mellitus Type 2 Treated With Empagliflozin","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}